Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Lipka

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Cancer Cell|December 12, 2018
From Basic Knowledge to Effective TherapiesDaniel B Lipka, Pavlo Lutsik, Christoph Plass
Blood|August 14, 2010
FLT3 as a therapeutic target in AML: still challenging after all these yearsThomas Kindler, Daniel B Lipka, Thomas Fischer
Seminars in Cancer Biology|October 2, 2017
Impact of DNA methylation programming on normal and pre-leukemic hematopoiesisJens Langstein, Michael D Milsom, Daniel B Lipka
Expert Opinion on Therapeutic Patents|March 2, 2013
Substituted purine and 7-deazapurine compounds as modulators of epigenetic enzymes: a patent evaluation (WO2012075381)Daniel B Lipka, Dirk Kuck, Christian Kliem, et al.
Human Molecular Genetics|July 14, 2020
Molecular tumor classification using DNA methylome analysisMartin Sill, Christoph Plass, Stefan M Pfister, et al.
Acta Haematologica|August 29, 2009
Wild-type JAK2 secondary acute erythroleukemia developing after JAK2-V617F-mutated primary myelofibrosisAndreas Kreft, Erik Springer, Daniel B Lipka, et al.
Seminars in Cancer Biology|August 22, 2020
Epigenomic technologies for precision oncologyDieter Weichenhan, Daniel B Lipka, Pavlo Lutsik, et al.
Thrombosis and Haemostasis|February 1, 2007
Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemiaFlorian Heidel, Daniel B Lipka, Charis von Auer, et al.
International Journal of Cancer|November 21, 2022
DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple-negative breast cancer patientsJoschka Hey, Coral Halperin, Mark Hartmann, et al.
Leukemia Research|June 17, 2008
The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemiaStefan Kasper, Frank Breitenbuecher, Yvette Hoehn, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Cancer Cell|December 12, 2018
From Basic Knowledge to Effective TherapiesDaniel B Lipka, Pavlo Lutsik, Christoph Plass
Blood|August 14, 2010
FLT3 as a therapeutic target in AML: still challenging after all these yearsThomas Kindler, Daniel B Lipka, Thomas Fischer
Seminars in Cancer Biology|October 2, 2017
Impact of DNA methylation programming on normal and pre-leukemic hematopoiesisJens Langstein, Michael D Milsom, Daniel B Lipka
Expert Opinion on Therapeutic Patents|March 2, 2013
Substituted purine and 7-deazapurine compounds as modulators of epigenetic enzymes: a patent evaluation (WO2012075381)Daniel B Lipka, Dirk Kuck, Christian Kliem, et al.
Human Molecular Genetics|July 14, 2020
Molecular tumor classification using DNA methylome analysisMartin Sill, Christoph Plass, Stefan M Pfister, et al.
Acta Haematologica|August 29, 2009
Wild-type JAK2 secondary acute erythroleukemia developing after JAK2-V617F-mutated primary myelofibrosisAndreas Kreft, Erik Springer, Daniel B Lipka, et al.
Seminars in Cancer Biology|August 22, 2020
Epigenomic technologies for precision oncologyDieter Weichenhan, Daniel B Lipka, Pavlo Lutsik, et al.
Thrombosis and Haemostasis|February 1, 2007
Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemiaFlorian Heidel, Daniel B Lipka, Charis von Auer, et al.
International Journal of Cancer|November 21, 2022
DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple-negative breast cancer patientsJoschka Hey, Coral Halperin, Mark Hartmann, et al.
Leukemia Research|June 17, 2008
The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemiaStefan Kasper, Frank Breitenbuecher, Yvette Hoehn, et al.
Pageof 9